RDIV vs. PBE

Last updated Jun 16, 2026

RDIV (Invesco S&P Ultra Dividend Revenue ETF) and PBE (Invesco Dynamic Biotechnology & Genome ETF) are both exchange-traded funds - RDIV is a Mid Cap Value Equities fund tracking the S&P 900 Dividend Revenue-Weighted Index, while PBE is a Health & Biotech Equities fund tracking the Dynamic Biotech & Genome Intellidex Index (AMEX). Both are passively managed. Over the past 10 years, RDIV returned 11.04%/yr vs 8.90%/yr for PBE. At a 0.40 correlation, their price movements are largely independent. RDIV charges 0.39%/yr vs 0.59%/yr for PBE.

Performance

RDIV vs. PBE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco S&P Ultra Dividend Revenue ETF (RDIV) and Invesco Dynamic Biotechnology & Genome ETF (PBE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, RDIV achieves a 14.73% return, which is significantly higher than PBE's 3.32% return. Over the past 10 years, RDIV has outperformed PBE with an annualized return of 11.04%, while PBE has yielded a comparatively lower 8.90% annualized return.

RDIV

• 1D: -1.73%
• 1M: 5.67%
• YTD: 14.73%
• 6M: 12.64%
• 1Y: 29.81%
• 3Y*: 18.46%
• 5Y*: 10.99%
• 10Y*: 11.04%

PBE

• 1D: 0.81%
• 1M: 4.85%
• YTD: 3.32%
• 6M: 5.17%
• 1Y: 34.13%
• 3Y*: 10.91%
• 5Y*: 2.31%
• 10Y*: 8.90%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RDIV vs. PBE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
RDIV Invesco S&P Ultra Dividend Revenue ETF	14.73%	12.36%	15.17%	4.66%	7.16%	29.12%	-9.31%	22.62%	-4.78%	11.63%
PBE Invesco Dynamic Biotechnology & Genome ETF	3.32%	24.84%	1.10%	3.71%	-10.83%	1.54%	25.66%	18.65%	-0.19%	22.28%

Correlation

The correlation between RDIV and PBE is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.34
Correlation (3Y) Calculated over the trailing 3-year period	0.50
Correlation (5Y) Calculated over the trailing 5-year period	0.50
Correlation (10Y) Calculated over the trailing 10-year period	0.43
Correlation (All Time) Calculated using the full available price history since Oct 1, 2013	0.40

The correlation between RDIV and PBE shifts across timeframes, from 0.34 (1 year) to 0.50 (3 years), reflecting how their relationship changes across market environments.

RDIV vs. PBE - Sectors Allocation Comparison

Sectors	RDIV	PBE
Financial Services	17.8%	0.2%
Energy	17.3%	-
Consumer Cyclical	15.0%	-
Consumer Defensive	14.6%	-
Communication Services	8.8%	-
Real Estate	7.3%	-
Healthcare	6.8%	99.9%
Technology	6.2%	-
Utilities	6.2%	-
Basic Materials	0.5%	-
Industrials	-	-

Return for Risk

RDIV vs. PBE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RDIV

RDIV Risk / Return Rank: 84
RDIV Sharpe Ratio Rank: 78
RDIV Sortino Ratio Rank: 83
RDIV Omega Ratio Rank: 74
RDIV Calmar Ratio Rank: 94
RDIV Martin Ratio Rank: 89

PBE

PBE Risk / Return Rank: 58
PBE Sharpe Ratio Rank: 58
PBE Sortino Ratio Rank: 63
PBE Omega Ratio Rank: 53
PBE Calmar Ratio Rank: 63
PBE Martin Ratio Rank: 52

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RDIV vs. PBE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco S&P Ultra Dividend Revenue ETF (RDIV) and Invesco Dynamic Biotechnology & Genome ETF (PBE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	RDIV	PBE	Difference
Sharpe ratio: Return per unit of total volatility	2.26	1.81	+0.45
Sortino ratio: Return per unit of downside risk	3.33	2.68	+0.65
Omega ratio: Gain probability vs. loss probability	1.39	1.31	+0.09
Calmar ratio: Return relative to maximum drawdown	6.18	2.92	+3.26
Martin ratio: Return relative to average drawdown	18.36	8.21	+10.15

RDIV vs. PBE - Sharpe Ratio Comparison

The current RDIV Sharpe Ratio is 2.26, which is comparable to the PBE Sharpe Ratio of 1.81. The chart below compares the historical Sharpe Ratios of RDIV and PBE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

RDIV vs. PBE - Drawdown Comparison

The maximum RDIV drawdown since its inception was -49.97%, which is greater than PBE's maximum drawdown of -45.69%. Use the drawdown chart below to compare losses from any high point for RDIV and PBE.

Drawdown Indicators

	RDIV	PBE	Difference
Max Drawdown Largest peak-to-trough decline	-49.97%	-45.69%	-4.28%
Max Drawdown (1Y) Largest decline over 1 year	-4.84%	-11.73%	+6.89%
Max Drawdown (3Y) Largest decline over 3 years	-17.91%	-22.43%	+4.52%
Max Drawdown (5Y) Largest decline over 5 years	-24.89%	-34.71%	+9.82%
Max Drawdown (10Y) Largest decline over 10 years	-49.97%	-37.84%	-12.13%
Current Drawdown Current decline from peak	-1.73%	-1.00%	-0.73%
Average Drawdown Average peak-to-trough decline	-5.85%	-16.21%	+10.36%
Ulcer Index Depth and duration of drawdowns from previous peaks	1.63%	4.17%	-2.54%

Volatility

RDIV vs. PBE - Volatility Comparison

The current volatility for Invesco S&P Ultra Dividend Revenue ETF (RDIV) is 4.07%, while Invesco Dynamic Biotechnology & Genome ETF (PBE) has a volatility of 6.04%. This indicates that RDIV experiences smaller price fluctuations and is considered to be less risky than PBE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RDIV	PBE	Difference
Volatility (1M) Calculated over the trailing 1-month period	4.07%	6.04%	-1.97%
Volatility (6M) Calculated over the trailing 6-month period	8.83%	13.67%	-4.84%
Volatility (1Y) Calculated over the trailing 1-year period	13.26%	19.01%	-5.75%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	17.56%	22.48%	-4.92%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	21.90%	24.91%	-3.01%

RDIV vs. PBE - Expense Ratio Comparison

RDIV has a 0.39% expense ratio, which is lower than PBE's 0.59% expense ratio.

Dividends

RDIV vs. PBE - Dividend Comparison

RDIV's dividend yield for the trailing twelve months is around 3.57%, more than PBE's 1.02% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
PBE Invesco Dynamic Biotechnology & Genome ETF	1.02%	1.00%	0.05%	0.02%	0.00%	0.00%	0.04%	0.00%	0.00%	0.57%	0.38%	1.12%
RDIV Invesco S&P Ultra Dividend Revenue ETF	3.57%	3.94%	4.08%	3.93%	3.44%	3.31%	4.93%	3.84%	4.32%	4.26%	2.20%	4.49%

Frequently Asked Questions

Can I hold both RDIV and PBE in my portfolio?

RDIV and PBE have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, RDIV or PBE?

PBE has higher volatility (6.04%) compared to RDIV (4.07%). In terms of maximum drawdown, RDIV dropped -49.97% vs PBE's -45.69%.

Which ETF is better, RDIV or PBE?

On 10-year performance, RDIV leads with 11.04% vs 8.90% for PBE. On fees, RDIV is cheaper at 0.39% per year. On volatility, RDIV has been the lower-risk option at 4.07%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, RDIV or PBE?

Over the 10-year period, RDIV has performed better with a 11.04% return vs 8.90%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, RDIV or PBE?

RDIV is cheaper with a 0.39% expense ratio, compared with 0.59% for PBE.

Which ETF pays a higher dividend yield, RDIV or PBE?

RDIV has the higher dividend yield at 3.57%, compared with 1.02% for PBE.

What is the main difference between RDIV and PBE?

RDIV is categorized as Mid Cap Value Equities, while PBE is Health & Biotech Equities. RDIV tracks S&P 900 Dividend Revenue-Weighted Index, while PBE tracks Dynamic Biotech & Genome Intellidex Index (AMEX). Their fees differ too: 0.39% for RDIV and 0.59% for PBE.

Which has better risk-adjusted returns?

RDIV currently has the higher Sharpe Ratio (2.26 vs 1.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.